MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
Bean, J., Brennan, C., Shih, J.-Y., Riely, G., Viale, A., Wang, L., Chitale, D., Motoi, N., Szoke, J., Broderick, S., Balak, M., Chang, W.-C., Yu, C.-J., Gazdar, A., Pass, H., Rusch, V., Gerald, W., HТом:
104
Мова:
english
Журнал:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.0710370104
Date:
December, 2007
Файл:
PDF, 593 KB
english, 2007
File converter
Більше результатів пошуку
More benefits 
